Treating multiple sclerosis with generic cladribine

被引：0
|
作者：
Alvarez-Gonzalez, C. [1 ,2 ]
Allen-Philbey, K. [2 ]
Mathews, J. [3 ]
Espasandin, M. [2 ]
Turner, B. P. [1 ,2 ]
Gnanapavan, S. [1 ,2 ]
Marta, M. [1 ,2 ]
Giovannoni, G. [1 ,2 ]
Baker, D. [1 ]
Schmierer, K. [1 ,2 ]
机构：
[1] Queen Mary Univ London, Barts & London Sch Med & Dent, Blizard Inst Neurosci, London, England
[2] Barts Hlth NHS Trust, Emergency Care & Acute Med Neurosci Clin Acad Grp, London, England
[3] Barts Hlth NHS Trust, Neurol & Med Safety, London, England
来源：
MULTIPLE SCLEROSIS JOURNAL | 2016年 / 22卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P1161
引用
收藏
页码：604 / 605
页数：2
相关论文
共 50 条
  • [41] CANCER RISK IN MULTIPLE SCLEROSIS PATIENTS TAKING CLADRIBINE
    Pakpoor, Julia
    Disanto, Giulio
    Altmann, Daniel R.
    Pavitt, Sue
    Turner, Benjamin
    Calado-Marta, Monica
    Juliusson, Gunnar
    Baker, David
    Chataway, Jeremy
    Schmierer, Klaus
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2014, 85 (10):
  • [42] Recommendations for the use of cladribine tablets in recurring multiple sclerosis
    Oreja-Guevara, Celia
    Garcia-Merino, Juan A.
    Saiz, Albert
    Rodriguez-Antiguedad, Alfredo
    Alvarez-Cermeno, Jose C.
    Estrada-Perez, Vicente
    Izquierdo, Guillermo
    Fernandez, Oscar
    REVISTA DE NEUROLOGIA, 2019, 69 : S1 - S9
  • [43] Cladribine has potential in multiple sclerosis, but is not without toxicity
    不详
    Drugs & Therapy Perspectives, 1998, 12 (12) : 1 - 4
  • [44] Cladribine: Mode of Action and Implications for Treatment of Multiple Sclerosis
    Leist, Thomas P.
    Weissert, Robert
    CLINICAL NEUROPHARMACOLOGY, 2011, 34 (01) : 28 - 35
  • [45] Eyebrow alopecia associated with cladribine treatment for multiple sclerosis
    Budimkic, Maja Stefanovic
    Ivanovic, Jovana
    Momcilovic, Nikola
    Mesaros, Sarlota
    Drulovic, Jelena
    NEUROLOGICAL SCIENCES, 2023, 44 (10) : 3735 - 3736
  • [46] Use of Cladribine for multiple sclerosis in a second level hospital
    Losa Lopez, L.
    Murgadella Sancho, A.
    Gracia Garcia, B.
    Puebla Villaescusa, A.
    Zubizarreta Nafarrate, I.
    Moral Torres, E.
    Hidalgo Albert, E.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2021, 43 (03) : 809 - 809
  • [47] CLADIN: CLADribine and INnate Immune responses in Multiple Sclerosis
    Sequeira, Richard
    Muscat, Andrea
    Stukey, Sian
    Minh, Viet
    Loftus, Naomi
    Voo, Veronica
    Fazzolari, Katherine
    Moss, Melinda
    Maltby, Vicki E.
    Sanfilippo, Paul
    Nguyen, Ai-Lan
    Wesselingh, Robb
    Seery, Nabil
    Nesbitt, Cassie
    Baker, Josephine
    Dwyer, Chris
    Taylor, Lisa
    Rath, Louise
    Van der Walt, Anneke
    Marriott, Mark
    Kalincik, Tomas
    Lechner-Scott, Jeannette
    O'Brien, Terence J.
    Butzkueven, Helmut
    Monif, Mastura
    MULTIPLE SCLEROSIS JOURNAL, 2024, 30 (04) : 49 - 49
  • [48] Cladribine TabletsIn Relapsing-Remitting Multiple Sclerosis
    Victoria J. Muir
    Greg L. Plosker
    CNS Drugs, 2011, 25 : 239 - 249
  • [49] An update on cladribine for relapsing-remitting multiple sclerosis
    Holmoy, Trygve
    Torkildsen, Oivind
    Myhr, Kjell-Morten
    EXPERT OPINION ON PHARMACOTHERAPY, 2017, 18 (15) : 1627 - 1635
  • [50] Cladribine tablets and multiple sclerosis: NICE technology appraisal
    Gaber, Tarek
    Shippen, Clare
    PROGRESS IN NEUROLOGY AND PSYCHIATRY, 2018, 22 (01) : 5 - 6
12345